G. Ransmayr et al., Striatal dopamine transporter function in dementia with Lewy bodies and Parkinson's disease, EUR J NUCL, 28(10), 2001, pp. 1523-1528
Citations number
35
Categorie Soggetti
Radiology ,Nuclear Medicine & Imaging","Medical Research Diagnosis & Treatment
The aim of this study was to compare parkinsonian features and loss of stri
atal dopamine transporter (DAT) function in patients with dementia with Lew
y bodies (DLB) and Parkinson's disease (PD), matched for age and disease du
ration. Twenty patients with DLB. 24 PD patients and 10 matched controls we
re examined with SPET using a dual-head camera and the dopamine-transporter
ligand I-123-beta -CIT (148 MBq). Moreover, in a subgroup of patients (16
DLB and 20 PD patients), subscores of the Unified Parkinson's Disease Ratin
g Scale (UPDRS) - motor examination (ME) subscale were obtained during "pra
ctical off", i.e. 12 h following withdrawal of antiparkinsonian therapy. Co
mpared with controls, striatal/cerebellar (S/C) ratios of DAT binding were
significantly reduced in both DLB and PD, deficits being more marked in DLB
patients (controls 7.2 +/-1.2. DLB 3.3 +/-1, PD 4.2 +/-1.4;, means +/- SD)
. The side-to-side differences in the S/C ratios were lower in the DLB grou
p and the controls than in PD patients (0.4 +/-0.4, 0.2 +/-0.2 and 0.6 +/-0
.3., respectively, P <0.05). The total UPDRS-ME scores during practical-off
were significantly higher in the DLB than in the PD group (41.2 +/- 12.7 v
s 26.6 +/- 15.3, P <0.01). The side-to-side differences of the summed UPDRS
extremity subscores were smaller in the DLB than in the PD group (2.2 +/-2
.3 vs 7.4 +/-3.9, P <0.0001). Our findings suggest that parkinsonism evolve
s largely symmetrically and progresses more rapidly with more severe loss o
f striatal dopamine transporter function in DLB compared to PD. Whether the
se findings are helpful in the differential diagnosis of DLB and PD needs t
o be examined in further studies.